Organization
The Leukemia & Lymphoma Society, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
The Leukemia & Lymphoma Society, Inc.
... been to identify a target that would allow the elimination of T-cell lymphoma while sparing healthy T-cells, as these play an essential role in providing ...
... (Kahler Disease), Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma, Lung Cancer, Lymphoma, Myelodysplastic Syndrome, Non-Hodgkin Lymphoma, Pancreatic Cancer, Chronic Lymphocytic Leukemia ...
... And Sex Hormones and Toxicology which include indications Breast Cancer, Mantle Cell Lymphoma, Metastatic Breast Cancer, Lymphoma, Non-Small Cell Lung Cancer, Colon Cancer, Colorectal Cancer, ...
... diseases, from rare conditions like hemophilia A to common blood cancers like lymphoma,' said Sandra Horning, M.D., chief medical officer and head of Global Product ...
... The Leukemia & Lymphoma Society (LLS) is going back where it all began - 30 ...
... describing preclinical research exploring the use of selinexor in models of AML, lymphoma, mantle cell lymphoma (MCL) and MM have also been selected for oral ...
... first-in-class BTK inhibitor IMBRUVICA in patients with relapsed or refractory Mantle Cell Lymphoma (MCL).The pooled analysis will be presented as an oral presentation at 12:00 ...
... like lymphoma, leukemia and sickle cell disease * Primary results of pivotal KymriahTM Phase ...
... kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.1 Experience the interactive ...
... 2017 (GLOBE NEWSWIRE) -- What:New York Road Runners & The Leukemia & Lymphoma Society, the world's largest voluntary health agency dedicated to fighting blood cancers, ...
... Leukemia), Amyloidosis, Breast Cancer, Chronic Lymphocytic Leukemia (CLL), Colon Cancer, Cutaneous T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Endometriosis, Glioblastoma Multiforme (GBM), Gliosarcoma, Hematological Tumor, Kidney ...
... a revolutionary new immunotherapy for adult patients with diffuse large B cell lymphoma, a form of non-Hodgkin's lymphoma. Yescarta is a Chimeric Antigen Receptor (CAR) ...
... The Leukemia & Lymphoma Society (LLS) hails today's U.S. Food and Drug Administration (FDA) approval ...
... for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell ...
... cells from patients with Sezary syndrome, a form of cutaneous T cell lymphoma (CTCL), express the CD47 "do not eat" signal at almost four times ...
... Acute Lymphoblastic Leukemia), Acute Promyelocytic Leukemia, Autoimmune Disorders, Dementia, Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Glioblastoma Multiforme (GBM), Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, ...
... efforts and walking as a team, IDI Consulting will support the Leukemia & Lymphoma Society and its fight against blood cancer on October 10th. IDI ...
... The United Food and Commercial Workers International Union (UFCW) and The Leukemia & Lymphoma Society (LLS) today announced the launch ofLabor Against Cancer,a movement to ...
... The Leukemia & Lymphoma Society's(LLS)Greater Bay Area chapter will host the Pacific Union Leukemia Cup ...
... achieving a response, as a new treatment for previously untreated advanced follicular lymphoma. The approval is based on results from the GALLIUM study, the first ...
... and CD22; two antigens expressed by cancer cells in B-cell leukaemia and lymphoma. AUTO3 is designed to minimise the risk of relapse due to antigen ...
... Choice Awards in association with the Breast Cancer Research Foundation, The Leukemia & Lymphoma Society (LLS), and the Pediatric Cancer Research Foundation (PCRF). JUMP, JIVE ...
... The Leukemia & Lymphoma Society's (LLS) is proud to announce its 16th consecutive year of ...
... placebo-controlled study evaluating SGX301 (synthetic hypericin) as a treatment for cutaneous T-cell lymphoma (CTCL). "We are appreciative of the financial support provided by NCI for ...
... approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. ...
... patients who tested negative for latent tuberculosis infection prior to initiating therapy. Lymphoma and other malignancies, some fatal, have been reported in children and adolescent ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤